FY2025 · ended Dec 31, 2025 · Revenue $241,000, +7.1% YoY · Filed Mar 23, 2026
Envoy Medical, Inc. (COCH) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $241,000 and a net loss of $23.8 million. Free cash flow was -$18.4 million.
Revenue (TTM)
$231,000
+11.1% vs year-ago TTM
Net income (TTM)
$-20.85M
+4.3% vs year-ago TTM
Operating cash flow (TTM)
$-22.23M
-26.3% vs year-ago TTM
Free cash flow (TTM)
$-22.44M
-23.7% vs year-ago TTM
EPS (TTM)
$-0.91
+79.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
76.88M
+260.5% vs prior year
Net cash
$2.82M
FY 2025
Operating margin
-10343.3%
FY 2026
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- COCH (Nasdaq), COCHW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- White Bear Lake, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1840877
- Former names
- Anzu Special Acquisition Corp I (until Sep 29, 2023)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $241,000 | $225,000 | $316,000 | — | — |
| Operating income | -$22.3M | -$19.3M | -$18.4M | -$8.7M | -$5.2M |
| Net income | -$23.8M | -$20.8M | -$29.9M | -$15.9M | -$251,633 |
| Diluted EPS | -$1.23 | -$1.49 | -$2.54 | — | — |
| Operating cash flow | -$18.2M | -$17.9M | -$17.1M | -$8.8M | -$3.2M |
| Free cash flow | -$18.4M | -$18.9M | -$17.2M | — | — |
| Total assets | $8.6M | $11.5M | $8.3M | $2.6M | $426.9M |
| Total liabilities | $20.3M | $30.4M | $10.0M | $38.8M | $38.6M |
| Stockholders' equity | -$12.2M | -$18.8M | -$1.8M | -$36.2M | -$45.0M |
| Cash and investments | $3.7M | $5.5M | $4.2M | $183,000 | $149,845 |
| Total debt | $919,000 | $945,000 | $562,000 | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 16, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Other events
|
Oct 7, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
All 328 Envoy Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.